Article
Negative allosteric modulation of cannabinoid CB1 receptor signaling suppresses…
medRxiv · 2024 · Iyer, V.; Saberi, S. A.; Pacheco, R.; Fender Sizemore, E.; Stockman, S.; Kulkarni, A.; Cantwell, L.; Thakur, G. A.; Hohmann, A. G.
Key facts
| Title | Negative allosteric modulation of cannabinoid CB1 receptor signaling suppresses opioid-mediated tolerance and withdrawal without blocking opioid antinociception |
|---|---|
| First author | Iyer, V.; Saberi, S. A.; Pacheco, R.; Fender Sizemore, E.; Stockman, S.; Kulkarni, A.; Cantwell, L.; Thakur, G. A.; Hohmann, A. G. |
| Journal | medRxiv |
| Published | Jan 1, 2024 |
| DOI | 10.1101/2024.01.06.574477 |
| Devices mentioned | K040782, K042152, K940422, K982100 |
| Product codes mentioned | CFN, DFZ, JAK, GIA |
At a glance
- 1–9 FDA submissions mentioned
- 1–9 Product codes mentioned
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Literature
Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.
Source: Publisher and PubMed metadata; device mentions identified by Orca1